C. Kollmannsberger

418 total citations
27 papers, 318 citations indexed

About

C. Kollmannsberger is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, C. Kollmannsberger has authored 27 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 9 papers in Surgery. Recurrent topics in C. Kollmannsberger's work include Renal cell carcinoma treatment (11 papers), Cancer Genomics and Diagnostics (6 papers) and Testicular diseases and treatments (5 papers). C. Kollmannsberger is often cited by papers focused on Renal cell carcinoma treatment (11 papers), Cancer Genomics and Diagnostics (6 papers) and Testicular diseases and treatments (5 papers). C. Kollmannsberger collaborates with scholars based in Canada, Germany and United States. C. Kollmannsberger's co-authors include Carsten Bokemeyer, Lothar Kanz, Frank Mayer, Roland Bares, Claus D. Claussen, B. Dohmen, Helmut Dittmann, Cédric Baumann, Lothar Kanz and Martin Sökler and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Annals of Oncology.

In The Last Decade

C. Kollmannsberger

25 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Kollmannsberger Canada 10 167 107 101 81 74 27 318
Mahsa Ahadi Australia 10 176 1.1× 99 0.9× 238 2.4× 107 1.3× 106 1.4× 26 445
Sugganth Daniel United States 7 96 0.6× 62 0.6× 196 1.9× 46 0.6× 67 0.9× 26 313
Eleonora Biasin Italy 10 130 0.8× 62 0.6× 79 0.8× 50 0.6× 22 0.3× 13 367
Jitka Abrahámová Czechia 10 182 1.1× 168 1.6× 147 1.5× 95 1.2× 32 0.4× 44 406
Cyril Foa France 12 181 1.1× 67 0.6× 181 1.8× 80 1.0× 40 0.5× 31 457
Maria Nirvana Formiga Brazil 12 186 1.1× 118 1.1× 142 1.4× 62 0.8× 42 0.6× 39 360
Fabiana Pani Italy 14 51 0.3× 66 0.6× 161 1.6× 67 0.8× 39 0.5× 28 446
Rieko Minami Japan 12 79 0.5× 96 0.9× 105 1.0× 48 0.6× 64 0.9× 20 287
Anne-Birgitte Jacobsen Norway 13 141 0.8× 45 0.4× 184 1.8× 196 2.4× 78 1.1× 30 452
Başak Oyan Türkiye 12 92 0.6× 68 0.6× 155 1.5× 54 0.7× 45 0.6× 39 348

Countries citing papers authored by C. Kollmannsberger

Since Specialization
Citations

This map shows the geographic impact of C. Kollmannsberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Kollmannsberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Kollmannsberger more than expected).

Fields of papers citing papers by C. Kollmannsberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Kollmannsberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Kollmannsberger. The network helps show where C. Kollmannsberger may publish in the future.

Co-authorship network of co-authors of C. Kollmannsberger

This figure shows the co-authorship network connecting the top 25 collaborators of C. Kollmannsberger. A scholar is included among the top collaborators of C. Kollmannsberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Kollmannsberger. C. Kollmannsberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanguay, Simon, Lori Wood, C. Kollmannsberger, et al.. (2025). Optimal Timing of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Patients Considering Sarcomatoid Status: A Real-World Study. Clinical Genitourinary Cancer. 23(3). 102342–102342. 1 indexed citations
2.
3.
Dinh, Paul C., Lawrence H. Einhorn, Darren R. Feldman, et al.. (2025). Impact of Population Pharmacogenomics on Cisplatin‐Induced Neurotoxicities in Testicular Cancer Survivors. Cancer Medicine. 14(17). e71218–e71218. 1 indexed citations
4.
Bacon, Jack V. W., Cameron Herberts, Cecily Q. Bernales, et al.. (2025). Clonal hematopoiesis in metastatic urothelial and renal cell carcinoma. npj Precision Oncology. 9(1). 177–177. 1 indexed citations
5.
6.
7.
Soleimani, Mohammad Ali, C. Kollmannsberger, Alan Bates, Bonnie Leung, & Cheryl Ho. (2020). Patient-reported psychosocial distress in adolescents and young adults with germ cell tumours. Supportive Care in Cancer. 29(4). 2105–2110. 9 indexed citations
8.
9.
Lavoie, Jean‐Michel, Gillian Vandekerkhove, Matti Annala, et al.. (2019). Circulating tumour DNA (ctDNA) utility as a biomarker for metastatic urothelial carcinoma (mUC). Annals of Oncology. 30. v376–v376.
10.
Donskov, Frede, Weibin Xie, J. Connor Wells, et al.. (2017). Synchronous vs metachronous metastatic disease: Impact of time to metastasis on outcome in metastatic renal cell carcinoma patients treated with targeted therapy. Annals of Oncology. 28. v311–v312. 1 indexed citations
11.
Fournel, Marielle, Nancy Beaulieu, Claire Bonfils, et al.. (2012). 312 A Novel Assay for the Met Inhibitory Activity of MGCD265 in Plasma From Solid Tumor Patients in a Dose Escalating Phase I Study. European Journal of Cancer. 48. 95–96. 4 indexed citations
12.
Tannir, Nizar M., C. Kollmannsberger, Marc S. Ernstoff, et al.. (2009). Phase II trial of ABT-869 in advanced renal cell cancer (RCC) after sunitinib failure: Efficacy and safety results. Journal of Clinical Oncology. 27(15_suppl). 5036–5036. 9 indexed citations
13.
Heng, D.Y.C. & C. Kollmannsberger. (2009). State-of-the-Art Treatment of Metastatic Renal Cell Carcinoma. Current Oncology. 16(11). 16–23. 4 indexed citations
14.
Heng, D.Y.C., Paul Elson, Ali Golshayan, et al.. (2008). A retrospective multicenter study of MSKCC poor-prognosis patients with metastatic renal cell carcinoma (mRCC) treated with sunitinib. Journal of Clinical Oncology. 26(15_suppl). 16057–16057. 4 indexed citations
15.
Oechsle, Karin, C. Kollmannsberger, B. Dohmen, et al.. (2004). [18F]FDG-PET, CT/MRT und Tumormarker als prädiktive Indikatoren für das Ansprechen unter Hochdosis-Chemotherapie bei Patienten mit metastasierten Keimzelltumoren. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 176(1). 76–84. 9 indexed citations
16.
Merseburger, Axel S., Gerd Wegener, Marcus Horstmann, et al.. (2003). Welche Tumorgröße korreliert am besten mit dem Progressionsrisiko lokal organbegrenzter Nierenzellkarzinome?. Aktuelle Urologie. 34(7). 469–474. 1 indexed citations
17.
Dittmann, Helmut, Martin Sökler, C. Kollmannsberger, et al.. (2001). Comparison of 18FDG-PET with CT scans in the evaluation of patients with residual and recurrent Hodgkin's lymphoma. Oncology Reports. 8(6). 1393–9. 55 indexed citations
18.
19.
Kollmannsberger, C., et al.. (1999). Late toxicity following curative treatment of testicular cancer. Seminars in Surgical Oncology. 17(4). 275–281. 55 indexed citations
20.
Kollmannsberger, C., Wolfram Brugger, Jörg T. Hartmann, et al.. (1999). Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma. Anti-Cancer Drugs. 10(5). 453–456. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mahsa Ahadi Breakdown of academic impact, for papers by Sugganth Daniel Breakdown of academic impact, for papers by Eleonora Biasin Breakdown of academic impact, for papers by Jitka Abrahámová Breakdown of academic impact, for papers by Cyril Foa Breakdown of academic impact, for papers by Maria Nirvana Formiga Breakdown of academic impact, for papers by Fabiana Pani Breakdown of academic impact, for papers by Rieko Minami Breakdown of academic impact, for papers by Anne-Birgitte Jacobsen Breakdown of academic impact, for papers by Başak Oyan
Rankless by CCL
2026